Back to results
US 2025/0049893 A1Published application
Manufacture, formulation and dosing of apraglutide
AssigneeVectivBio AG
InventorsFederico BOLOGNANI, Gleb FELDMAN
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods of making, formulating and administering GLP-2 analogs.
Claims29
A method of treating short bowel syndrome (SBS) in a subject, the method comprising administering apraglutide, or a pharmaceutically acceptable salt thereof, to the subject once weekly at a dose between 1 mg and 10 mg.
Dependencies are inferred from the claim text.